Bloomberg Businessweek
All Eyes on Gilead
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:20:10
- Mais informações
Informações:
Sinopse
Emergency approval of the antiviral drug remdesivir is the first good news of this pandemic. This is how Gilead Sciences prepared for the moment. Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.
